pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT01072331: Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07002931: Titanium Mesh vs Customized PEEK Mesh for Horizontal Maxillary Ridge Augmentation: A Randomized Clinical Trial

    Sponsor: Basma Alsheikh. Phase: NA. Conditions: Alveolar Bone Atrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05634902: Implementation of Evidence-Based Practice for Dizziness

    Sponsor: Ohio State University. Phase: NA. Conditions: BPPV, Vestibular Diseases, Vertigo, Dizziness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07612553: MitrAl Valve Calcium aSsEssmEnt With TrueVue Trans-illumination 3D Rendering.

    Sponsor: Centro Cardiologico Monzino. Phase: . Conditions: Mitral Annular Calcification, Mitral Valve Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07319637: Comparing Two Types of Surgery for Children With Undescended Testicles When the Hernia Sac Is Tied or Not

    Sponsor: Children Hospital Faisalabad. Phase: NA. Conditions: Undescended Testis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07294729: Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions

    Sponsor: Medipol University. Phase: NA. Conditions: Rotator Cuff Syndrome, Rotator Cuff Injuries

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01917331: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

    Sponsor: Chiesi Farmaceutici S.p.A.. Phase: PHASE3. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05451602: HEC169096 in Participants With Advanced Solid Tumors

    Sponsor: Sunshine Lake Pharma Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04640753: Peroral Endoscopic Myotomy for the Treatment of Achalasia

    Sponsor: Methodist Health System. Phase: . Conditions: Achalasia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06886737: Home-based Vision Therapy

    Sponsor: VA Office of Research and Development. Phase: PHASE1. Conditions: Convergence Insufficiency

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07695129: Hemorrhagic Shock in Orthopedic Fractures

    Sponsor: Sohag University. Phase: . Conditions: Hemorrhagic Shock, Pelvic Fractures, Long Bone Fractures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00361829: The Influence of Maternal Age, Employment Status, and Parenthood Status on Children's Cognitive Development

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Child Development

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06340529: Comparison of the Perception of Non-technical Skills

    Sponsor: University of Valencia. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06142929: Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Dupuytren's Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05397431: A Survey of Lanadelumab in Participants With Hereditary Angioedema

    Sponsor: Takeda. Phase: . Conditions: Hereditary Angioedema (HAE)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03716531: Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Pancreas Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04912531: Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Postoperative Pain, Anxiety Postoperative, Opioid Use

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04141631: Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Cardiac Surgery, Transfusion, Perioperative Anemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04216953: MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

    Sponsor: Centre Leon Berard. Phase: PHASE1. Conditions: Sarcoma,Soft Tissue

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07054853: Effect of Induced Rotator Cuff Muscles Fatigue on Hand Grip Strength in Adults

    Sponsor: Noura Karam Abdou Mohammed Ismaiel. Phase: . Conditions: Healthy Individuals

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07647237: A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo

    Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Vitiligo

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07536737: Impact of PDT and Topical Corticosteroids on Taste Perception and Salivary Oxidative Stress Markers in Patients With OLP

    Sponsor: Medical University of Bialystok. Phase: NA. Conditions: Oral Lichen Planus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07645729: Evaluation of a Powered Ankle Prosthesis Capable of Bidirectional Control Via Neural Recording and Cutaneous Stimulation in Free-Space and Walking Tasks

    Sponsor: Massachusetts Institute of Technology. Phase: NA. Conditions: Amputation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07515729: Raising Awareness of Colorectal Screening in American Indian Communities

    Sponsor: University of Oklahoma. Phase: . Conditions: Colorectal Cancer (CRC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06452602: Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

    Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07566702: Effect of Neuromuscular Electrical Stimulation on Muscle Mass in ECMO Patients

    Sponsor: Cairo University. Phase: NA. Conditions: Muscle Mass Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06628453: CGM for Management of Type 2 Diabetes in Pregnancy

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM), Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07705737: Rademikibart IV for Acute Asthma and COPD Exacerbation

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute, COPD Exacerbation Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06994637: Effects of Liquid Hourglass and Spiky Ball on Pain, Fear, Anxiety and Emotional Manifestations

    Sponsor: Hakkari Universitesi. Phase: NA. Conditions: Pain, Anxiety and Fear, Procedural Anxiety, Procedural Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07503951: Cognitive Behavior Therapy in Psychiatric Inpatient Care

    Sponsor: Region Stockholm. Phase: NA. Conditions: Depression, Anxiety Disorders, Psychiatric Inpatients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04207931: Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE4. Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626502: Immediate vs Delayed Postpartum Implanon-NXT

    Sponsor: Assiut University. Phase: . Conditions: Delayed and Secondary Postpartum Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06776653: Impact of a Snoezelen Element on Anxiety in Patients During Oral Care: A Real-Life Study at Nantes University Hospital

    Sponsor: Nantes University Hospital. Phase: . Conditions: Odontologic Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07108153: Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

    Sponsor: Sionna Therapeutics Inc.. Phase: PHASE2. Conditions: Cystic Fibrosis (CF)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06536894: Fibromyalgia Syndrome on Anthropometric and Ultrasonographic Measurements in Obstructive Sleep Apnea Syndrome

    Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Fibromyalgia Syndrome, Obstructive Sleep Apnea Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05164094: A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

    Sponsor: ModernaTX, Inc.. Phase: PHASE1. Conditions: Epstein-Barr Virus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362056: Implementing Suicide Prevention Into Primary Care in Nepal

    Sponsor: Yale University. Phase: NA. Conditions: Suicide, Primary Care

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06957756: A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Hepatic Insufficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07316556: Post-Marketing Surveillance of Vliwazell® Prowound Dressing

    Sponsor: Lohmann & Rauscher. Phase: . Conditions: Acute and Chronic Wounds

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07436156: SUMMIT RISE Study of Acute Ischemic Stroke Patients

    Sponsor: Route 92 Medical, Inc.. Phase: PHASE4. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05689151: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

    Sponsor: Pfizer. Phase: . Conditions: Atopic Dermatitis, Eczema

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03016156: Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

    Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Retinoblastoma, Cataracts Infantile, Glaucoma, Congenital, Leucocoria

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01500551: Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04800029: Telehealth to Improve Prevention of Suicide (TIPS)

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Suicide Risk

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07595302: Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain

    Sponsor: Montefiore Medical Center. Phase: PHASE4. Conditions: Pelvic Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07692802: Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes

    Sponsor: CHA University. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07337902: Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Crohn's Disease (CD), Dysmenorrhea Primary

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06850402: Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cervical Cancer, HIV

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634653: Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Leukemia, Acute Leukemia, Acute Lymphoid Leukemia, Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07232537: An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

    Sponsor: Bayer. Phase: . Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ← prev
    page 84 of 98
    next →